Literature DB >> 26720627

Tuberculosis Contact Investigations--United States, 2003-2012.

Kai H Young, Melissa Ehman, Randall Reves, Brandy L Peterson Maddox, Awal Khan, Terence L Chorba, John Jereb.   

Abstract

Mycobacterium tuberculosis is transmitted through the air from an infectious patient (index patient) to other persons (contacts) who share space. Exposure to M. tuberculosis can result in tuberculosis (TB) disease or latent TB infection (LTBI), which has no clinical symptoms or radiologic evidence of disease. The cycle of transmission can be ended by isolating and treating patients with TB disease, examining contacts, and treating LTBI to prevent progression to TB disease. CDC systematically collects aggregate data on contact investigations from the 50 states, the District of Columbia (DC), and Puerto Rico. Data from 2003-2012 were analyzed for trends in yields from contact investigations, in terms of numbers of contacts elicited and examined and the estimated number of TB cases averted through treatment of LTBI among contacts in 2012. During 2003-2012, the number of TB cases decreased, while the number of contacts listed per index patient with contacts elicited increased. In 2012, U.S. public health authorities reported 9,945 cases of TB disease (1) and 105,100 contacts. Among these contacts, 84,998 (80.9%) were examined; TB was diagnosed in 532 (0.6%) and LTBI in 15,411 (18.1%). Among contacts with LTBI, 10,137 (65.8%) started treatment, and 6,689 (43.4% of all contacts with LTBI) completed treatment. By investigating contacts in 2012, an estimated 128 TB cases (34% of all potential cases) over the initial 5 years were averted, but an additional 248 cases (66%) might have been averted if all potentially contagious TB patients had contacts elicited, all contacts were examined, and all infected contacts completed treatment. Enhancing contact investigation activities, particularly by ensuring completion of treatment by contacts recently infected with M. tuberculosis, is essential to achieve the goal of TB elimination.

Entities:  

Mesh:

Year:  2016        PMID: 26720627     DOI: 10.15585/mmwr.mm6450a1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  15 in total

1.  CE: Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States.

Authors:  John Parmer; Leeanna Allen; Wanda Walton
Journal:  Am J Nurs       Date:  2017-08       Impact factor: 2.220

Review 2.  Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.

Authors:  Philip A LoBue; Jonathan H Mermin
Journal:  Lancet Infect Dis       Date:  2017-05-08       Impact factor: 25.071

3.  Delivering multi-disease screening to migrants for latent TB and blood-borne viruses in an emergency department setting: A feasibility study.

Authors:  Sally Hargreaves; Laura B Nellums; Catherine Johnson; Jacob Goldberg; Panagiotis Pantelidis; Asif Rahman; Jon S Friedland FMedSci
Journal:  Travel Med Infect Dis       Date:  2020-02-29       Impact factor: 6.211

4.  Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis.

Authors:  Sourya Shrestha; Sarah Cherng; Andrew N Hill; Sue Reynolds; Jennifer Flood; Pennan M Barry; Adam Readhead; Margaret Oxtoby; Michael Lauzardo; Tom Privett; Suzanne M Marks; David W Dowdy
Journal:  Am J Epidemiol       Date:  2019-09-01       Impact factor: 4.897

5.  Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.

Authors:  Mary R Reichler; Awal Khan; Timothy R Sterling; Hui Zhao; Joyce Moran; James McAuley; Patricia Bessler; Bonita Mangura
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

6.  COVID-19 Case Investigation and Contact Tracing in the US, 2020.

Authors:  R Ryan Lash; Patrick K Moonan; Brittany L Byers; Robert A Bonacci; Kimberly E Bonner; Matthew Donahue; Catherine V Donovan; Heather N Grome; Julia M Janssen; Reed Magleby; Heather P McLaughlin; James S Miller; Caroline Q Pratt; Jonathan Steinberg; Kate Varela; Greta L Anschuetz; Paul R Cieslak; Veronica Fialkowski; Aaron T Fleischauer; Clay Goddard; Sara Jo Johnson; Michelle Morris; Jill Moses; Allison Newman; Lauren Prinzing; Alana C Sulka; Puthiery Va; Matthew Willis; John E Oeltmann
Journal:  JAMA Netw Open       Date:  2021-06-01

7.  Contact tracing strategies in household and congregate environments to identify cases of tuberculosis in low- and moderate-incidence populations.

Authors:  Darryl Braganza Menezes; Bunota Menezes; Martin Dedicoat
Journal:  Cochrane Database Syst Rev       Date:  2019-08-28

8.  Tuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured.

Authors:  Erica L Stockbridge; Thaddeus L Miller; Erin K Carlson; Christine Ho
Journal:  J Public Health Manag Pract       Date:  2018 Jul/Aug

9.  Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011-2012.

Authors:  James D Mancuso; Roque Miramontes; Carla A Winston; C Robert Horsburgh; Andrew N Hill
Journal:  Ann Am Thorac Soc       Date:  2021-10

10.  An evaluation of tuberculosis contact investigations against national standards.

Authors:  Sean M Cavany; Tom Sumner; Emilia Vynnycky; Clare Flach; Richard G White; H Lucy Thomas; Helen Maguire; Charlotte Anderson
Journal:  Thorax       Date:  2017-04-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.